These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18181273)

  • 1. Failed HIV vaccine may have increased vulnerability to infection.
    Clin Infect Dis; 2008 Jan; 46(1):iii. PubMed ID: 18181273
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV vaccine may raise risk.
    Ledford H
    Nature; 2007 Nov; 450(7168):325. PubMed ID: 18004331
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical research. A setback and an advance on the AIDS vaccine front.
    Cohen J
    Science; 2003 Apr; 300(5616):28-9. PubMed ID: 12677027
    [No Abstract]   [Full Text] [Related]  

  • 4. The therapeutic phase I trial of the recombinant native HIV-1 Tat protein.
    Ensoli B; Fiorelli V; Ensoli F; Lazzarin A; Visintini R; Narciso P; Di Carlo A; Monini P; Magnani M; Garaci E
    AIDS; 2008 Oct; 22(16):2207-9. PubMed ID: 18832884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV/AIDS vaccines: a need for new concepts?
    Girard MP; Bansal GP
    Int Rev Immunol; 2008; 27(6):447-71. PubMed ID: 19065351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dendritic cell vaccine is a hope for alternative treatment of HIV infection].
    Kahl U
    Lakartidningen; 2003 Jun; 100(25):2224. PubMed ID: 12872511
    [No Abstract]   [Full Text] [Related]  

  • 7. Don't stop me now.
    Nat Immunol; 2008 Aug; 9(8):821. PubMed ID: 18645584
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV-1 T-cell vaccines: evaluating the next step.
    Pantaleo G
    Lancet Infect Dis; 2008 Feb; 8(2):82-3. PubMed ID: 18060842
    [No Abstract]   [Full Text] [Related]  

  • 9. The two faces of vaccine-induced immune response: protection or increased risk of HIV infection?!
    Temchura V; Tenbusch M
    Virol Sin; 2014 Feb; 29(1):7-9. PubMed ID: 24452542
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV adenovirus vaccine in Phase I trials.
    Expert Rev Vaccines; 2003 Aug; 2(4):471. PubMed ID: 14711332
    [No Abstract]   [Full Text] [Related]  

  • 11. An HIV vaccine--challenges and prospects.
    Johnston MI; Fauci AS
    N Engl J Med; 2008 Aug; 359(9):888-90. PubMed ID: 18753644
    [No Abstract]   [Full Text] [Related]  

  • 12. Human versus HIV: round 2 defeat in AIDS vaccine development.
    Lu S
    Expert Rev Vaccines; 2008 Mar; 7(2):151-3. PubMed ID: 18324884
    [No Abstract]   [Full Text] [Related]  

  • 13. Predicting the potential impact of a cytotoxic T-lymphocyte HIV vaccine: how often should you vaccinate and how strong should the vaccine be?
    Smith RJ; Schwartz EJ
    Math Biosci; 2008 Apr; 212(2):180-7. PubMed ID: 18359048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine trial discontinued.
    AIDS Patient Care STDS; 2007 Oct; 21(10):778-9. PubMed ID: 17992718
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV vaccine failure prompts Merck to halt trial.
    Nature; 2007 Sep; 449(7161):390. PubMed ID: 17898737
    [No Abstract]   [Full Text] [Related]  

  • 16. Modeling the population level effects of an HIV-1 vaccine in an era of highly active antiretroviral therapy.
    Rida W; Sandberg S
    Bull Math Biol; 2009 Apr; 71(3):648-80. PubMed ID: 19214640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled clinical phase I trial with combined anti-HIV-1 and anti-interferon-alpha immunization.
    Coulaud IP; Gougeon ML; Gomard E; Descamps D; Lebon P; Aboulker JP; Bizzini B; Zagury D
    AIDS; 1997 Jun; 11(7):937-8. PubMed ID: 9189226
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV vaccine controversy.
    Jayaraman KS
    Nat Biotechnol; 2008 Mar; 26(3):256. PubMed ID: 18327224
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV-1 vaccine candidate ineffective.
    Barouch DH
    AIDS Clin Care; 2007 Nov; 19(11):93. PubMed ID: 18399000
    [No Abstract]   [Full Text] [Related]  

  • 20. NIH begins second Phase I clinical trial of HIV vaccine.
    IAVI Rep; 2004 Dec-2005 Mar; 9(1):15. PubMed ID: 16110571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.